drugset / Trial / NCT06561061
Zinc for Infection Prevention in Sickle Cell Anemia-2 (ZIPS-2)
Phase 2/3
Completed
100 enrolled
Indiana University
Global Health Uganda LTD · collabMakerere University · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
A randomized double-blinded placebo-controlled trial of zinc to reduce the incidence of severe or invasive infections in Ugandan children with sickle cell anemia (SCA)
Timeline
- Start
- 2025-02-10
- Primary completion
- 2025-11-07
- Completion
- 2025-11-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zinc Sulfate | Unknown | 20 mg | Oral |